344 related articles for article (PubMed ID: 34924021)
1. Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy.
Gavriilaki E; Ho VT; Schwaeble W; Dudler T; Daha M; Fujita T; Jodele S
Exp Hematol Oncol; 2021 Dec; 10(1):57. PubMed ID: 34924021
[TBL] [Abstract][Full Text] [Related]
2. Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
Schoettler ML; Patel S; Bryson E; Deeb L; Watkins B; Qayed M; Chandrakasan S; Fitch T; Silvis K; Jones J; Chonat S; Williams KM
Transplant Cell Ther; 2024 Mar; 30(3):336.e1-336.e8. PubMed ID: 38145741
[TBL] [Abstract][Full Text] [Related]
3. The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems.
Dobó J; Kocsis A; Farkas B; Demeter F; Cervenak L; Gál P
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338844
[TBL] [Abstract][Full Text] [Related]
4. Rare variants in complement system genes associate with endothelial damage after pediatric allogeneic hematopoietic stem cell transplantation.
Leimi L; Koski JR; Kilpivaara O; Vettenranta K; Lokki AI; Meri S
Front Immunol; 2023; 14():1249958. PubMed ID: 37771589
[TBL] [Abstract][Full Text] [Related]
5. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
[TBL] [Abstract][Full Text] [Related]
6. A journey through the lectin pathway of complement-MBL and beyond.
Garred P; Genster N; Pilely K; Bayarri-Olmos R; Rosbjerg A; Ma YJ; Skjoedt MO
Immunol Rev; 2016 Nov; 274(1):74-97. PubMed ID: 27782323
[TBL] [Abstract][Full Text] [Related]
7. Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy.
Khaled SK; Claes K; Goh YT; Kwong YL; Leung N; Mendrek W; Nakamura R; Sathar J; Ng E; Nangia N; Whitaker S; Rambaldi A;
J Clin Oncol; 2022 Aug; 40(22):2447-2457. PubMed ID: 35439028
[TBL] [Abstract][Full Text] [Related]
8. Genetic Susceptibility in Endothelial Injury Syndromes after Hematopoietic Cell Transplantation and Other Cellular Therapies: Climbing a Steep Hill.
Evangelidis P; Evangelidis N; Kalmoukos P; Kourti M; Tragiannidis A; Gavriilaki E
Curr Issues Mol Biol; 2024 May; 46(5):4787-4802. PubMed ID: 38785556
[TBL] [Abstract][Full Text] [Related]
9. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).
Świerzko AS; Michalski M; Sokołowska A; Nowicki M; Eppa Ł; Szala-Poździej A; Mitrus I; Szmigielska-Kapłon A; Sobczyk-Kruszelnicka M; Michalak K; Gołos A; Wierzbowska A; Giebel S; Jamroziak K; Kowalski ML; Brzezińska O; Thiel S; Jensenius JC; Kasperkiewicz K; Cedzyński M
Front Immunol; 2018; 9():2153. PubMed ID: 30294330
[TBL] [Abstract][Full Text] [Related]
10. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
11. Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44.
Degn SE; Jensen L; Olszowski T; Jensenius JC; Thiel S
J Immunol; 2013 Aug; 191(3):1334-45. PubMed ID: 23785123
[TBL] [Abstract][Full Text] [Related]
12. Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology.
Milone G; Bellofiore C; Leotta S; Milone GA; Cupri A; Duminuco A; Garibaldi B; Palumbo G
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160072
[TBL] [Abstract][Full Text] [Related]
13. Complement System as a New Target for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy.
Ardissino G; Capone V; Tedeschi S; Porcaro L; Cugno M
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890144
[TBL] [Abstract][Full Text] [Related]
14. The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy.
Sartain S; Shubert S; Wu MF; Wang T; Martinez C
Pediatr Blood Cancer; 2020 Mar; 67(3):e28070. PubMed ID: 31774252
[TBL] [Abstract][Full Text] [Related]
15. MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab.
Elhadad S; Chapin J; Copertino D; Van Besien K; Ahamed J; Laurence J
Clin Exp Immunol; 2021 Jan; 203(1):96-104. PubMed ID: 32681658
[TBL] [Abstract][Full Text] [Related]
16. Neurological involvement in hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Liu W; Zhu X; Xiao Y
Ann Hematol; 2024 May; ():. PubMed ID: 38763940
[TBL] [Abstract][Full Text] [Related]
17. The emerging roles of mannose-binding lectin-associated serine proteases (MASPs) in the lectin pathway of complement and beyond.
Dobó J; Pál G; Cervenak L; Gál P
Immunol Rev; 2016 Nov; 274(1):98-111. PubMed ID: 27782318
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Jodele S; Licht C; Goebel J; Dixon BP; Zhang K; Sivakumaran TA; Davies SM; Pluthero FG; Lu L; Laskin BL
Blood; 2013 Sep; 122(12):2003-7. PubMed ID: 23814021
[TBL] [Abstract][Full Text] [Related]
19. Narsoplimab for severe transplant-associated thrombotic microangiopathy.
Pandrowala A; Ganatra P; Krishnan VP; Sharma AN; Chavan S; Bodhanwala M; Agarwal B; Hiwarkar P
Thromb J; 2023 Mar; 21(1):26. PubMed ID: 36915123
[TBL] [Abstract][Full Text] [Related]
20. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway.
Takahashi M; Iwaki D; Kanno K; Ishida Y; Xiong J; Matsushita M; Endo Y; Miura S; Ishii N; Sugamura K; Fujita T
J Immunol; 2008 May; 180(9):6132-8. PubMed ID: 18424734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
